Stonepine Capital Management, LLC
CIK: 0001440771Latest portfolio: $137.0M · Q4 2025
Holdings
64
Total Value
$137.0M
New Positions
28
Closed Positions
22
Top Holdings
View All 64 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | VSTMVERASTEM INC | 2,732,079 | $21.1M | 15.40% | +62K | |
| 2 | ADMAADMA BIOLOGICS INC | 740,000 | $13.5M | 9.85% | +1K | |
| 3 | EOLSEVOLUS INC | 1,631,588 | $10.8M | 7.92% | +95K | |
| 4 | NKTRNEKTAR THERAPEUTICS | 135,000 | $5.7M | 4.17% | NEW | Call |
| 5 | ZVRAZEVRA THERAPEUTICS INC | 569,088 | $5.1M | 3.72% | -240,912 | |
| 6 | IKTINHIBIKASE THERAPEUTICS INC | 2,348,147 | $4.8M | 3.51% | +1.6M | |
| 7 | ABEOABEONA THERAPEUTICS INC | 909,505 | $4.8M | 3.50% | NEW | Call |
| 8 | —INDIVIOR PLC | 100,000 | $3.6M | 2.62% | — | |
| 9 | CRBPCORBUS PHARMACEUTICALS HLDGS | 389,916 | $3.2M | 2.32% | NEW | |
| 10 | KZIAKAZIA THERAPEUTICS LTD | 460,359 | $3.2M | 2.32% | NEW | |
| 11 | XOMAXOMA ROYALTY CORPORATION | 115,000 | $3.1M | 2.23% | -459 | |
| 12 | VRCAVERRICA PHARMACEUTICALS INC | 353,669 | $2.9M | 2.14% | NEW | |
| 13 | HELPCYBIN INC | 339,902 | $2.8M | 2.03% | NEW | |
| 14 | TELATELA BIO INC | 2,352,032 | $2.8M | 2.03% | +197K | |
| 15 | ACADACADIA PHARMACEUTICALS INC | 100,000 | $2.7M | 1.95% | -74,544 | |
| 16 | CRSPCRISPR THERAPEUTICS AG | 50,000 | $2.6M | 1.91% | NEW | Call |
| 17 | SRZNSURROZEN INC | 113,631 | $2.6M | 1.87% | -136,515 | |
| 18 | AREALEXANDRIA REAL ESTATE EQ IN | 50,000 | $2.4M | 1.79% | NEW | Call |
| 19 | XFORX4 PHARMACEUTICALS INC | 593,573 | $2.4M | 1.73% | -462,765 | |
| 20 | RAREULTRAGENYX PHARMACEUTICAL IN | 100,000 | $2.3M | 1.68% | NEW | Call |
| 21 | AYTUAYTU BIOPHARMA INC | 813,704 | $2.1M | 1.54% | -78,151 | |
| 22 | DAWNDAY ONE BIOPHARMACEUTICALS I | 200,000 | $1.9M | 1.36% | -447,382 | |
| 23 | ACETADICET BIO INC | 220,011 | $1.9M | 1.35% | NEW | |
| 24 | SPRBSPRUCE BIOSCIENCES INC | 19,742 | $1.7M | 1.26% | NEW | |
| 25 | HRTXHERON THERAPEUTICS INC | 1,237,802 | $1.6M | 1.17% | +388K |
Quarterly Changes
New Positions
Increased Positions
Sector Breakdown
Healthcare0.0% ($2.1091134971085056e+195T)
Unknown0.0% ($35881063.8T)
Real Estate0.0% ($2.4M)
Filing History
Fund Information
Stonepine Capital Management, LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $137.0M across 64 holdings. The largest position is VERASTEM INC (VSTM), representing 15.4% of the portfolio. Compared to the previous quarter, the fund opened 32 new positions and closed 26 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.